A factual note on regulatory status: both semaglutide and tirzepatide are approved prescription drugs in various jurisdictions for clinical indications, but in the Canadian research-supply context they are sold strictly as research-grade compounds and are not approved by Health Canada for the research uses discussed here
Regulations, eligibility requirements, and GLP-1 availability vary by state and individual health profile
Both effects stem from the same GLP-1 receptor activation that slows gastric emptying
A 5 to 10 beat per minute increase that a 35-year-old barely notices might cause fatigue, exercise intolerance, or shortness of breath in a 65-year-old
On the flip side, eating balanced meals, centered around protein, vegetables, and complex carbs, even within a moderate fasting window, can support weight loss
Section 8: Patient Experiences and Anecdotes Patient experiences and anecdotal accounts can provide valuable firsthand insights into the potential effects of semaglutide, including brand names like Ozempic and Mounjaro, on the menstrual cycle